Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Tumor Protein P63 (TP63) Peptid

TP63 Reaktivität: Human Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN985398

Kurzübersicht für Tumor Protein P63 (TP63) Peptid (ABIN985398)

Target

p63 (TP63) (Tumor Protein P63 (TP63))

Spezies

Human

Quelle

  • 5
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-TP63 antibody (Catalog #: ARP38379_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    p63 (TP63) (Tumor Protein P63 (TP63))

    Hintergrund

    TP63 is a member of the p53 family of transcription factors. An animal model, p63 -/- mice, has been useful in defining the role this protein plays in the development and maintenance of stratified epithelial tissues. p63 -/- mice have several developmental defects which include the lack of limbs and other tissues, such as teeth and mammary glands, which develop as a result of interactions between mesenchyme and epithelium. Mutations in the gene encoding TP63 are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3), split-hand/foot malformation 4 (SHFM4), ankyloblepharon-ectodermal defects-cleft lip/palate, ADULT syndrome (acro-dermato-ungual-lacrimal-tooth), limb-mammary syndrome, Rap-Hodgkin syndrome (RHS), and orofacial cleft 8.This gene encodes a member of the p53 family of transcription factors. An animal model, p63 -/- mice, has been useful in defining the role this protein plays in the development and maintenance of stratified epithelial tissues. p63 -/- mice have several developmental defects which include the lack of limbs and other tissues, such as teeth and mammary glands, which develop as a result of interactions between mesenchyme and epithelium. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3), split-hand/foot malformation 4 (SHFM4), ankyloblepharon-ectodermal defects-cleft lip/palate, ADULT syndrome (acro-dermato-ungual-lacrimal-tooth), limb-mammary syndrome, Rap-Hodgkin syndrome (RHS), and orofacial cleft 8. Both alternative splicing and the use of alternative promoters results in multiple transcript variants encoding different proteins. Many transcripts encoding different proteins have been reported but the biological validity and the full-length nature of these variants have not been determined.

    Alias Symbols: B(p51A), B(p51B), EEC3, KET, LMS, OFC8, RHS, SHFM4, TP73L, p51, p63, p73H, p73L, AIS, NBP, p40, TP53L, p53CP, TP53CP

    Protein Interaction Partner: FAS,DAXX,EP300,GRB2,HIPK2,HNRNPAB,PPP1R13B,PPP2R5A,TP53,TP63,TP73,WT1,BTRC,GNB2L1,HIPK2,HNRNPAB,SFRS15,UBC,YAP1

    Protein Size: 586

    Molekulargewicht

    65 kDa

    Gen-ID

    8626

    NCBI Accession

    NM_001114980, NP_001108452

    UniProt

    Q9H3D4
Sie sind hier:
Chat with us!